Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
Main Authors: | Shamim Rafat, Sahu Sandeep, Siddiqui Tasneem, Agarwal Sanjay |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Journal of Anaesthesiology Clinical Pharmacology |
Online Access: | http://www.joacp.org/article.asp?issn=0970-9185;year=2017;volume=33;issue=3;spage=422;epage=423;aulast=Rafat |
Similar Items
-
Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
by: Ngan N. Lam, MD, et al.
Published: (2021-08-01) -
Guillain–Barre syndrome after antithymocyte globulin administration in a kidney transplant recipient: A case report and literature review
by: Farnaz Tavakoli, et al.
Published: (2023-11-01) -
Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
by: Hoa Le Mai, PhD, et al.
Published: (2018-04-01) -
PB2188: APPLICATION PROSPECT OF LOW DOSE PORCINE ANTITHYMOCYTE GLOBULIN IN HLA MATCHED SIBLING DONOR TRANSPLANTATION
by: X. chen, et al.
Published: (2022-06-01) -
Basiliximab vs. Antithymocyte Globulin as Initial Induction Therapy for Lung Transplantation: A National Two Years Review
by: Bruno Mendes, et al.
Published: (2022-08-01)